Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma. | Sci Rep | 2021 | 34429454 | PubTator, text mining | PubMed |
| Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer. | World J Surg Oncol | 2021 | 34419055 | PubTator, text mining | PubMed |
| ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood. | Cancer Sci | 2021 | 34418240 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. | Sci Rep | 2021 | 34413339 | PubTator, text mining | PubMed |
| LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. | Oncoimmunology | 2021 | 34408925 | PubTator, text mining | PubMed |
| Cytokines and apoptosis in atopic dermatitis. | Postepy Dermatol Alergol | 2021 | 34408560 | PubTator, text mining | PubMed |
| Live cell tagging tracking and isolation for spatial transcriptomics using photoactivatable cell dyes. | Nat Commun | 2021 | 34404785 | PubTator, text mining | PubMed |
| COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use. | Endocr Metab Sci | 2021 | 34396353 | PubTator, text mining | PubMed |
| Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/-/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611. | Front Oncol | 2021 | 34395258 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients. | Front Immunol | 2021 | 34394120 | PubTator, text mining | PubMed |
| CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway. | J Oral Pathol Med | 2021 | 34392586 | PubTator, text mining | PubMed |
| Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. | Front Cell Dev Biol | 2021 | 34386499 | PubTator, text mining | PubMed |
| [The immunoregulatory functions of exosome derived from mesenchymal stem cells that are genetically modified by adeno-associated virus]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34384150 | PubTator, text mining | PubMed |
| Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells. | Sci Rep | 2021 | 34376762 | PubTator, text mining | PubMed |
| Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. | Cell Discov | 2021 | 34373443 | PubTator, text mining | PubMed |
| Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis. | Pharmaceutics | 2021 | 34371756 | PubTator, text mining | PubMed |
| Sex Differences in Inflammation During Venous Remodeling of Arteriovenous Fistulae. | Front Cardiovasc Med | 2021 | 34368264 | PubTator, text mining | PubMed |
| Cell Fate Reprogramming in the Era of Cancer Immunotherapy. | Front Immunol | 2021 | 34367185 | PubTator, text mining | PubMed |
| Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1. | Front Immunol | 2021 | 34367166 | PubTator, text mining | PubMed |
| Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs. | Front Immunol | 2021 | 34367154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=78